ANI Pharmaceuticals
ANIP
ANIP
170 hedge funds and large institutions have $499M invested in ANI Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $664M → $499M (-$165M)
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
170
Holding in Top 10
–
Calls
$3.63M
Puts
$2.6M
Top Buyers
| 1 | +$10M | |
| 2 | +$7.54M | |
| 3 | +$3.3M | |
| 4 |
QI
QS Investors
New York
|
+$2.1M |
| 5 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
+$2.08M |
Top Sellers
| 1 | -$29.4M | |
| 2 | -$18.5M | |
| 3 | -$11.3M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$10.4M |
| 5 |
Citigroup
New York
|
-$4.79M |